These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split? Laberge L; Dauvilliers Y; Bégin P; Richer L; Jean S; Mathieu J Neuromuscul Disord; 2009 Jun; 19(6):397-402. PubMed ID: 19403309 [TBL] [Abstract][Full Text] [Related]
7. Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients. Laberge L; Mathieu J; Auclair J; Gagnon É; Noreau L; Gagnon C Eur Neurol; 2013; 70(5-6):308-15. PubMed ID: 24158106 [TBL] [Abstract][Full Text] [Related]
8. Further evidence for the reliability and validity of the Fatigue and Daytime Sleepiness Scale. Gallais B; Gagnon C; Forgues G; Côté I; Laberge L J Neurol Sci; 2017 Apr; 375():23-26. PubMed ID: 28320135 [TBL] [Abstract][Full Text] [Related]
9. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2. Tieleman AA; Knoop H; van de Logt AE; Bleijenberg G; van Engelen BG; Overeem S J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):963-7. PubMed ID: 20798200 [TBL] [Abstract][Full Text] [Related]
10. Impact of a 12-week Strength Training Program on Fatigue, Daytime Sleepiness, and Apathy in Men with Myotonic Dystrophy Type 1. Gallais B; Roussel MP; Laberge L; Hébert LJ; Duchesne E J Neuromuscul Dis; 2022; 9(5):629-639. PubMed ID: 35848033 [TBL] [Abstract][Full Text] [Related]
13. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation. Dauvilliers YA; Laberge L Sleep Med Rev; 2012 Dec; 16(6):539-45. PubMed ID: 22465566 [TBL] [Abstract][Full Text] [Related]
14. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Lam EM; Shepard PW; St Louis EK; Dueffert LG; Slocumb N; McCarter SJ; Silber MH; Boeve BF; Olson EJ; Somers VK; Milone M Neurology; 2013 Jul; 81(2):157-64. PubMed ID: 23749798 [TBL] [Abstract][Full Text] [Related]
15. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Heatwole C; Bode R; Johnson N; Quinn C; Martens W; McDermott MP; Rothrock N; Thornton C; Vickrey B; Victorson D; Moxley R Neurology; 2012 Jul; 79(4):348-57. PubMed ID: 22786587 [TBL] [Abstract][Full Text] [Related]
16. Quality of life and excessive daytime sleepiness in children and adolescents with myotonic dystrophy type 1. Ho G; Widger J; Cardamone M; Farrar MA Sleep Med; 2017 Apr; 32():92-96. PubMed ID: 28366348 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial. Puymirat J; Bouchard JP; Mathieu J Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232 [TBL] [Abstract][Full Text] [Related]
18. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Gibbs JW; Ciafaloni E; Radtke RA Sleep; 2002 Sep; 25(6):662-5. PubMed ID: 12224846 [TBL] [Abstract][Full Text] [Related]
19. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study. Yu H; Laberge L; Jaussent I; Bayard S; Scholtz S; Raoul M; Pages M; Dauvilliers Y Sleep; 2011 Feb; 34(2):165-70. PubMed ID: 21286250 [TBL] [Abstract][Full Text] [Related]